← Open Payments lookup

QUAN THAI: Open Payments

NPI 1700029105 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$594 in 20 payments from 12 companies in 2025. Trend: 2023 $378 · 2024 $348 · 2025 $594

Food & beverage: $594
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.1$128
AstraZeneca Pharmaceuticals LP4$81
Daiichi Sankyo Inc.3$64
Merck Sharp & Dohme LLC2$59
GlaxoSmithKline, LLC.2$54
Novartis Pharmaceuticals Corporation2$49
Janssen Biotech, Inc.1$39
Stemline Therapeutics Inc.1$29
Regeneron Healthcare Solutions, Inc.1$25
ABBVIE INC.1$24

Products named: OPDIVO, CALQUENCE, OJJAARA, Vanflyta, Fabhalta, TALVEY, KEYTRUDA, ELZONRIS.

Industry payments across CA — which companies pay providers there.